• Editors-in-Chief

    Graham Packham, PhD

    Professor of Molecular Oncology, University of Southampton, Southampton, UK
    Email: G.K.Packham@soton.ac.uk

    Nicola Normanno, MD

    Chief of Cell Biology and Biotherapy Unit, Director of Translational Research Department, Istituto Nazionale Tumori "Fondazione Pascale" Via Mariano Semmola, Naples, Italy
    Email: nicnorm@yahoo.com
    Associate Editors

    Francesco Bertoni, MD

    Interests: lymphoma; novel drugs; genomics; BET; PI3K
    Head, Lymphoma Genomics, deputy director, Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland

    Giovanni Blandino, MD

    Interests: tumor suppressors; non-coding RNA; Hippo pathway; PI3K inhibitors; HNSCC
    Head of Oncogenomic and Epigenetic Unit, Translation Research Coordinator CTC IFO/IRE, Regina Elena Cancer Institute, via Elio Chianesi 53 - 00144, Rome, Italy

    Giuseppe Curigliano, MD, PhD

    Interests: breast cancer; early drug development; precision oncology; biomarkers; NGS
    Associate Professor of Medical Oncology, University of Milan; Head, Division of Early Drug Development, European Institute of Oncology, Milan, Italy

    Gennaro Daniele, MD, PhD

    Interests: drug development; clinical trials; translational research; gynecologic malignancies; biomarkers
    Scientific Director, Clinical Trials Center, Agostino Gemelli University Policlinic, Rome, Italy

    Massimo Di Maio, MD

    Interests: clinical trials; meta-analysis; patient-reported outcomes; methodology; quality of life
    Director, Division of Medical Oncology, A.O. Ordine Mauriziano; Associate Professor of Medical Oncology, Department of Oncology, University of Turin, Torino, Italy

    Jianxun Ding, PhD

    Interests: polymer chemistry; biomaterial; controlled drug delivery; immunotherapy; regenerative medicine
    Associate Professor, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China

    Alan L. Epstein, MD, PhD

    Interests: cancer immunotherapy; antibody targeting; tumor antigens; CAR T-cell therapy; tumor models
    Professor of Pathology, Department of Pathology, University of Southern California, Los Angeles, USA

    A. Ganesan, PhD

    Interests: medicinal chemistry; chemical biology; organic synthesis; epigenetics; natural products
    Professor in Chemical Biology, School of Pharmacy, University of East Anglia, Norwich, UK

    Antonio Giordano, MD, PhD

    Interests: genetics; molecular biology; pathology; oncology; environment
    Present Professor, Department of Biology and Medicine; Present Director, Sbarro Health Research Organization; Present Director, Center of Biotechnology; Present Director, Professional Master Program (PSM) in Bioinnovation; Temple University, Philadelphia, PA, USA. Present “Chiara Fama” Professor, Department of Medical Biotechnology, University of Siena, Italy

    Marius Ilie, MD, PhD

    Interests: pathology; lung cancer; biomarkers; liquid biopsy; precision pathology
    Professor of Pathology, Université Côte d'Azur; Surgical Pathologist, Nice University Hospital, Nice, France

    Nagesh Kalakonda, PhD

    Interests: B-cell malignancies; clinical trials; drug therapy and signalling
    Reader and Honorary Consultant, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK

    Chunsheng Kang, MD, PhD

    Interests: nano-medicine; signaling pathways; exosome and endocytosis; gene editing; neuro-oncology
    Deputy Director of Tianjin Neurology Institute, Director of neuro-tumor laboratory of Tianjin Medical University General Hospital, Tianjin, China

    Simon Langdon, MA, PhD

    Interests: ovarian cancer; breast cancer; estrogen signaling; HER signaling; DNA repair
    Reader, School of Medicine, University of Edinburgh, Edinburgh, UK

    Wanliang Lu, PhD

    Interests: resistant cancer; cancer stem cells; gene regulation; nanomaterials; liposomes
    Professor and Vice Dean, School of Pharmaceutical Sciences, Peking University, China

    Maurie Markman, MD

    Interests: ovarian cancer; gynecologic malignancies; endometrial cancer, cervix cancer; targeted therapeutics
    President, Cancer Treatment Centers of America Medicine & Science; Chief Clinical Officer, CTCA Health, 1331 E. Wyoming Ave., Philadelphia, PA, USA

    Erika Martinelli, MD, PhD

    Interests: colorectal cancer; translational research; resistance to targeted therapies; gastrointestinal cancer
    Associate Professor in Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania L. Vanvitelli, Naples, Italy

    Alessandro Morabito, MD

    Interests: lung cancer; target based agents; angiogenesis inhibitors; immunotherapy; clinical trials
    Director of Thoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione Pascale" Via Mariano Semmola, Naples, Italy

    David Rizzieri, MD

    Interests: stem cell transplant; cellular therapy and CAR-T; leukemia; lymphoma; clinical trials
    Professor of Medicine, Duke University Medical Center; Chief, Section of Hematologic Malignancies, Duke Cancer Institute, Durham, USA

    Arun Seth, PhD

    Interests: precision oncology; breast and prostate cancer biology; molecular diagnostics; genomic profiling; next-generation sequencing; targeted cancer therapy
    Scientific Director of Molecular Diagnostics, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre; Academic Director, Genomics Core Facility, Senior Scientist, Sunnybrook Research Institute; Professor, Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Canada

    Gautam Sethi, PhD

    Interests: signal transduction; apoptosis; transcription factors; metastasis; mouse models of cancer
    Associate Professor, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    Valerie Speirs, PhD

    Interests: oestrogen receptor biology; endocrine resistant breast cancer; male breast cancer; in vitro models; biomarker
    Professor and Chair in Molecular Oncology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK

    Hua Tang, MD, PhD

    Interests: noncoding RNA; tumorigenesis; metastasis; virus; biotherapy
    Professor of Molecular Biology & Microbiology, Director of Tianjin Life Science Research Center, Chair of Department of Pathogen Biology, Tianjin Medical University, Tianjin, China
    Editorial Board Members

    Luca Agnelli, PhD

    Interests: lymphoid malignancies; bioinformatics and biostatistics in cancer; -omics analyses; NGS; non-coding RNA
    Post-doc, Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy

    Matthias Baud, PhD

    Interests: chemical biology; medicinal chemistry; small molecule; organic synthesis
    Lecturer in Medicinal Chemistry and Chemical Biology, University of Southampton, Southampton, UK

    Rossana Berardi, MD

    Interests: chest and breast cancers; neuroendocrine tumors; SIADH; clinical research (innovative drugs); translational research
    Professor in Medical Oncology and Director of the Postgraduate School of Medical Oncology at Università Politecnica Marche; Director of Department of Medical Oncology, Director of “Genetic Cancer” Center and Breast Unit Coordinator at Ospedali Riuniti of Ancona, Italy

    Angela Celetti, MD, PhD

    Interests: Tumor suppresor genes; biomarkers; DNA damage response and repair; synthetic lethality; poly(ADP-ribose) polymerases (PARPs) inhibitors
    Senior Staff Scientist, Institute of Endocrinology and Experimental Oncology “G.Salvatore”, CNR, Naples, Italy

    Laura Cerchia, PhD

    Interests: aptamers; cell-SELEX; cancer theranostics; cell-surface receptors; tumor‐targeted drug delivery
    Research Scientist, Group Leader, Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy

    Mark Cragg, PhD

    Interests: antibody immunotherapy; apoptosis; Fc gamma receptors; TNF RECEPTORS; CD20
    Professor of Experimental Cancer Research, Director of Cancer Pathway Integrated Postgraduate Programme, University of Southampton, Southampton, UK

    Eyad Elkord, PhD

    Interests: tumor immunology; cancer immunotherapy; immunosuppression; T regulatory cells; cancer epigenetics
    Principal Investigator and Professor, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar; Honorary Professor, University of Manchester, UK

    Marco Falasca, PhD (EQ)

    Interests: signal transduction; pancreatic cancer; drug development; lipid metabolism; exosomes
    Professor in Metabolism, School of Pharmacy & Biomedical Sciences, Curtin University, Perth, Australia

    Vanesa Gregorc, MD

    Interests: thoracic neoplasm; lung cancer; pleural mesothelioma; thymus cancer; immuno-oncology
    Thoracic Oncology, Head and Neck and Melanoma Area Coordinator, IRCSS Scientific Institute, University Hospital San Raffaele, Milan, Italy

    Valentina Guarneri, MD

    Interests: breast cancer; acute myeloid leukemia; HER2-posite breast cancer; videos breast cancer
    Associate Professor of Oncology, University of Padua, Padua, Italy